TD Cowen analyst Phil Nadeau reiterated a Buy rating on Cabaletta Bio (NASDAQ: CABA).The analyst comments "Cabaletta continues to execute ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE